Tianjin, China

Yongli Wang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Hainan Lingkang Pharmaceutical Co., Ltd, Tianjin University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yongli Wang. Retrieved from https://idiyas.com/inventor/yongli-wang-85qurqui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yongli Wang in Pharmaceutical Crystallization

Introduction

Yongli Wang is a notable inventor based in Tianjin, China, recognized for his contributions to the field of pharmaceutical crystallization. He holds two patents that focus on novel crystalline forms of important pharmaceutical compounds. His work has significant implications for the development and preparation of medications.

Latest Patents

Wang's latest patents include the "Crystalline form of cefamandole nafate compound, preparation and preparing method thereof." This patent defines a novel crystalline form characterized by specific diffraction angles in X-ray powder diffraction patterns and unique peaks in differential scanning calorimetry (DSC). The preparation method involves creating a suspension of Cefamandole Nafate in an organic solvent, stirring at controlled temperatures, and then cooling to achieve the desired crystalline form.

Another significant patent is the "Crystal form of Cefathiamidine compound and preparation method therefor." This invention describes a novel crystalline form of Cefathiamidine, characterized by its X-ray powder diffraction pattern and differential scanning calorimetry thermogram. The preparation method includes dissolving the compound in a solvent, adding a solventing-out agent, and carefully controlling the cooling process to obtain the crystalline form.

Career Highlights

Yongli Wang has worked with prominent institutions such as Tianjin University and Hainan Lingkang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Wang has collaborated with notable colleagues, including Hongxun Hao and Linggang Tao, who have supported his research endeavors in the field of pharmaceutical sciences.

Conclusion

Yongli Wang's innovative work in the crystallization of pharmaceutical compounds showcases his significant contributions to the industry. His patents not only advance the understanding of crystalline forms but also enhance the preparation methods for essential medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…